19. PATIENT CHARACTERISTICS & PK Flashcards

(38 cards)

1
Q

List pharmacokinetic factors that affect the dosage regimen

A

ADME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List clinical factors that affect the dosage regimen

A
  • patient factors: age, weight, race, sex disease, etc.
  • therapy factors: drugs, convenience, compliance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List activity/toxicity factors that affect the dosage regimen

A
  • therapeutic window
  • adverse effects
  • toxicity
  • concentration/response relationship
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List other factors that affect the dosage regimen

A
  • route of administration
  • dosage form
  • tolerance/sensitivity
  • pharmacogenomics
  • drug interactions
  • cost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What should ALWAYS be kept in mind when dosing pediatric patients?

A

CHILDREN ARE NOT SMALL ADULTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the Vd difference between adults and pediatric pts

A
  • younger patients have higher VD (“water balloon”)
  • increased absorption of hydrophilic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T/F: pediatric patients are homogenous

A

FALSE!
differentiate throughout development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a issue with dosing pediatric patients?

A

limited information about peds dosing (missing in ~75% of drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What route of administration is rarely used in peds pts?

A

IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the topical absorption difference between adults and pediatric pts

A

increased topical absorption in peds pts (higher conc) due to thinner skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the protein binding difference between adults and pediatric pts

A

Decreased protein binding in newborns & infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the most reliable route of administration for peds pts?

A

rectal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe aging effects that can impact distribution

A
  • Decreased lean body mass
  • Decreased total body water
  • Increased body fat

with advancing age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe impacts on elimination due to aging

A
  • AGE-RELATED CHANGE IN RENAL FUNCTION!
  • Reduced muscle mass (decreased SeCr)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is it important to consider the effects of aging when using the SeCr of older adults?

A

Estimation of renal function using SeCr may be less reliable in older adults due to reduced muscle mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is it important to consider the effects of aging when dosing renally eliminated drugs in older adults?

A
  • Decreased renal Cl of drugs that are eliminated by glomerular filtration and active tubular secretion with increasing age
  • Lower dosing for renally eliminated drugs
17
Q

List some PK (ADME) differences between men & women

A
  • Women typically have higher concentrations of drug and therefore a greater chance for adverse effects
  • Women have greater CYP3A activity (20-50% higher than men)
  • Women tend to have slower GFR & secretion
  • Men have slightly higher CYP2C19 & 2E1 activity
18
Q

Explain why women have a higher risk of developing cardiac arrythmias vs. men

A

Longer QT prolongation

19
Q

Explain why women have higher concentrations of drug than men

A
  • Women have a higher % of body fat compared to men
  • Women have greater Vd for lipophilic drugs
  • Women have smaller Vd for hydrophilic drugs & smaller plasma volumes

Higher exposure if not corrected for body weight

20
Q

What is a “sex difference”?

A

Differences cause by biological hormones

21
Q

What is a “gender difference”?

A

lifestyle differences (due to gender norms)

22
Q

T/F: The FDA considers “sex” and “gender” to be interchangeable

23
Q

Describe differences in distribution caused by pregnancy

A
  • Increase in total body water & expanded plasma volume = increased Vd of hydrophilic drugs
  • Increased body fat = increased Vd of lipophilic drugs
24
Q

Describe differences in elimination caused by pregnancy

A
  • Increased hepatic blood flow = Increased elimination of high hepatic extraction drugs
  • Increased renal blood flow & GFR = Increased elimination of renally eliminated drugs
25
What should obesity be considered?
a disease state
26
What factors determine distribution in obese patients?
- Body mass increases are heterogeneously distributed - Physiochemical properties of drug - Side effects of disease state
27
Describe the effects of obesity on hydrophilic drugs
Increase in Vd → total body water in increased *dosed based on IBW, LBW, or AdjBW*
28
Describe the effects of obesity on lipophilic drugs
Increased Vd, adjusted for body weight *usually dosed based on TBW (total body weight)*
29
Describe the effects of obesity on metabolism
- INCREASED CYP2E1 substrate clearance - DECREASED CYP3A4 activity *suggestive of decreased activity of CYP2C19, and CYP2D6*
30
Describe the effects of obesity on excretion
Increase in GFR → increased Renal Cl
31
How does estimating renal function of oebse pts with AdjBW compare to GFR?
usually an underestimation of GFR *used clinically for antibiotics*
32
How does estimating renal function of obese pts with Actual BW compare to GFR?
usually an overestimation of GFR *will overdose pt*
33
How does estimating renal function of obese pts with IBW compare to GFR?
usually an underestimation of GFR *used for insurance*
34
What is the best modified weight to use to estimate renal function in obese pts?
Lean Body Weight (LBW) *only used clinically if severly overweight*
35
When would BSA dosing be used clinically?
for dosing certain chemotherapies
36
What are loading doses (LD) calculated based on for obese pts?
primarily based on Vd
37
What are maintenance doses (MD) calculated based on for obese pts?
primarily based on drug clearance (Cl)
38
What weight should be used to calculate LD for obese pts?
Weight used to calculate LD dependent on how the drug is distributed into lean & fat tissue: - If primarily distributed into lean mass, use IBW - If primarily distributed into fat tissue (large spaces), use TBW - If distributed into both lean and fat tissues, use AdjBW